a p-Value was calculated using Wilcoxon rank sum test. *Statistically significant at alpha = 0.05. Statistically detectable MAR was recorded among Enterococcus spp. isolates [Figure 2 and Additional file 1]. E. faecium resistant to β-lactam class of antimicrobials including methicillin was recorded to be higher in this landscape. A large scale dissemination of aminoglycoside resistance was observed along the landscape gradient; higher percentage of gentamicin resistant enterococci were prevalent at site 3 which reflects its frequent use in human medicine as this

site receives wastes from hospital located just upstream. Our observations indicate that streptomycin and gentamicin resistance are distributed extensively in the environmental gene pool.

The resistance to erythromycin, a macrolide and rifampicin in association www.selleckchem.com/products/ldn193189.html with vancomycin, a glycopeptide was also distributed significantly. Hasman et al. [27], reported a relationship between copper, glycopeptide and macrolide resistance among E. faecium strains isolated from pigs in Denmark during 1997–2003, this website contemplating persistence of BPAR in that geographic region. A number of studies have reported the phenomenon of sustained BPAR in poultry and local population [28, 29]. Figure 2 Distribution of single/multiple-antimicrobial-resistance in different Enterococcus spp. Abbreviations: A, ampicillin; P, penicillinG; M, methicillin; G, gentamicin; S, streptomycin (aminoglycoside); Va, vancomycin (glycopeptide); Te, teicoplanin; E, erythromycin; R, rifampicin; T, tetracycline;

P-M, penicillinG-methicillin; A-P-Ox-M, ampicillin-penicillinG-oxacillin-methicillin (β-lactam); E-R, erythromycin-rifampicin (Macrolide-rifamycin); PD173074 Va-G-S/Va-S/Va-G (glycopeptide-aminoglycoside); M-G-S/P-G-S (β-lactam-aminoglycoside); Va-M (glycopeptide-β-lactam); T-E-R (tetracycline-macrolide-rifamycin); E-R-Va (macrolide-rifamycin-glycopeptide); E-R-Va-M (macrolide-rifamycin-glycopeptide-β-lactam); E-R-M/E-R-A/E-R-P Sorafenib cost (macrolide-rifamycin-β-lactam); E-R-G/E-R-S (macrolide-rifamycin-aminoglycoside); E-R-S-M/E-R-G-M (macrolide-rifamycin-aminoglycoside-β-lactam). All antimicrobial combinations derived from aforementioned antimicrobial abbreviations. Though the frequency of VRE is only 21% in the landscape, its association with other widely disseminated antimicrobials and virulence determinants may lead to evolution of pathogenic VRE and thus reduce the chances for synergistic therapy in case of failure of single antimicrobial [30]. Recently, Lata et al. [31] reported the prevalence of vanA gene (for vancomycin resistance) in surface waters of river Ganga and its tributary and discussed the possible consequences of BPAR, its environmental carriage by plasmid maintenance systems or postsegregational killing (PSK) systems.